Active hexose activated admixture (AHCC) is an alpha-glucan-rich comestible supplement extracted from Basidiomycota mushrooms, such as shiitake (Lentinula edodes).
AHCC is anticipation to activate the allowed arrangement and to abate the adverse furnishings of chemotherapy. AHCC was developed in Japan in 1992 and may accept antioxidant and anticancer activity, anticipate the access of diabetes, and anticipate alarmist injury.
AHCC has been apparent to abate chemotherapy-related ancillary furnishings and enhance antitumor effects. Early affirmation suggests that AHCC supplementation may advance the cast of blight patients. However, there are not abundant extracts to accomplish a conclusion. Further analysis is needed.